{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:15:33Z","timestamp":1775711733796,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372888, 82303662, 82102769"],"award-info":[{"award-number":["82372888, 82303662, 82102769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372888, 82303662, 82102769"],"award-info":[{"award-number":["82372888, 82303662, 82102769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372888, 82303662, 82102769"],"award-info":[{"award-number":["82372888, 82303662, 82102769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Peking University Clinical Scientist Training Program","award":["BMU2024PYJH008"],"award-info":[{"award-number":["BMU2024PYJH008"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M730121"],"award-info":[{"award-number":["2023M730121"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Clinical Research Center for Obstetrics and Gynecology","award":["BYSYSZKF2023031"],"award-info":[{"award-number":["BYSYSZKF2023031"]}]},{"name":"Ningxia Key Research and Development Program","award":["2023BEG01001"],"award-info":[{"award-number":["2023BEG01001"]}]},{"name":"Clinical Cohort Construction Program of Peking University Third Hospital","award":["BYSYDL2023010"],"award-info":[{"award-number":["BYSYDL2023010"]}]},{"name":"Key Clinical Projects of Peking University Third Hospital","award":["BYSYZD2021006"],"award-info":[{"award-number":["BYSYZD2021006"]}]},{"name":"Peking University-Golden Resource \u201cTengyun Clinical Research Program\u201d","award":["TY2025002"],"award-info":[{"award-number":["TY2025002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14835-0","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:47:47Z","timestamp":1756363667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological features of Chinese ovarian cancer patients with double heterozygosity for cancer-predisposed genes"],"prefix":"10.1186","volume":"25","author":[{"given":"Yikun","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"14835_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371: m3773.","journal-title":"BMJ"},{"issue":"4","key":"14835_CR2","first-page":"280","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280\u2013304.","journal-title":"CA Cancer J Clin"},{"issue":"10177","key":"14835_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240\u201353.","journal-title":"Lancet"},{"issue":"9","key":"14835_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrc.2016.72","volume":"16","author":"FC Nielsen","year":"2016","unstructured":"Nielsen FC, Van Overeem Hansen T, Sorensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways[J]. Nat Rev Cancer. 2016;16(9):599\u2013612.","journal-title":"Nat Rev Cancer"},{"key":"14835_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103046","author":"M Pavanello","year":"2020","unstructured":"Pavanello M, Chan IH, Ariff A, et al. Rare germline genetic variants and the risks of epithelial ovarian cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12103046.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"14835_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ng0197-14","volume":"15","author":"SJ Ramus","year":"1997","unstructured":"Ramus SJ, Friedman LS, Gayther SA, et al. A breast\/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Nat Genet. 1997;15(1):14\u20135.","journal-title":"Nat Genet"},{"issue":"11","key":"14835_CR7","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/nm1196-1179","volume":"2","author":"P Tonin","year":"1996","unstructured":"Tonin P, Weber B, Offit K, et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 1996;2(11):1179\u201383.","journal-title":"Nat Med"},{"issue":"6","key":"14835_CR8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1086\/301889","volume":"62","author":"A Liede","year":"1998","unstructured":"Liede A, Rehal P, Vesprini D, et al. A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2. Am J Hum Genet. 1998;62(6):1543\u20134.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"14835_CR9","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/annonc\/mdq460","volume":"22","author":"O Lavie","year":"2011","unstructured":"Lavie O, Narod S, Lejbkowicz F, et al. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Ann Oncol. 2011;22(4):964\u20136.","journal-title":"Ann Oncol"},{"key":"14835_CR10","doi-asserted-by":"crossref","unstructured":"Rebbeck TR, Friebel TM, Mitra N, EMBRACE, HEBON, et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res. 2016;18(1):112.","DOI":"10.1186\/s13058-016-0768-3"},{"issue":"3","key":"14835_CR11","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1136\/jmg.2004.027243","volume":"42","author":"B Leegte","year":"2005","unstructured":"Leegte B, Van Der Hout AH, Deffenbaugh AM, et al. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet. 2005;42(3):e20.","journal-title":"J Med Genet"},{"issue":"3","key":"14835_CR12","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10549-012-2050-4","volume":"134","author":"S Heidemann","year":"2012","unstructured":"Heidemann S, Fischer C, Engel C, et al. Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat. 2012;134(3):1229\u201339.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"14835_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.4143\/crt.2021.791","volume":"54","author":"YJ Bang","year":"2022","unstructured":"Bang YJ, Kwon WK, Nam SJ, et al. Clinicopathological characterization of double heterozygosity for BRCA1 and BRCA2 variants in Korean breast cancer patients. Cancer Res Treat. 2022;54(3):827\u201333.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"14835_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10549-024-07409-4","volume":"208","author":"S Wen","year":"2024","unstructured":"Wen S, Zhang M, Chen J, et al. Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants. Breast Cancer Res Treat. 2024;208(1):155\u201364.","journal-title":"Breast Cancer Res Treat"},{"key":"14835_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142547","author":"A Kwong","year":"2024","unstructured":"Kwong A, Ho CYS, Au CH, et al. Double heterozygosity for germline mutations in Chinese breast cancer patients. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16142547.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"14835_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-024-07362-2","volume":"207","author":"NC Van Der Merwe","year":"2024","unstructured":"Van Der Merwe NC, Buccimazza I, Rossouw B, et al. Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients. Breast Cancer Res Treat. 2024;207(2):331\u201342.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"14835_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ygyno.2019.11.019","volume":"156","author":"C Le Page","year":"2020","unstructured":"Le Page C, Rahimi K, Rodrigues M, et al. Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: a systematic review and case report analysis. Gynecol Oncol. 2020;156(2):377\u201386.","journal-title":"Gynecol Oncol"},{"key":"14835_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ygyno.2025.03.017","volume":"195","author":"Y Li","year":"2025","unstructured":"Li Y, Wu M, Liu Q, et al. Development and validation of an ovarian cancer risk assessment tool for first-degree relatives of patients in the Chinese population. Gynecol Oncol. 2025;195:165\u201372.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"14835_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"13","key":"14835_CR20","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313(13):1347\u201361.","journal-title":"JAMA"},{"issue":"4","key":"14835_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/hmg\/ddr525","volume":"21","author":"C Turnbull","year":"2012","unstructured":"Turnbull C, Seal S, Renwick A, et al. Gene-gene interactions in breast cancer susceptibility. Hum Mol Genet. 2012;21(4):958\u201362.","journal-title":"Hum Mol Genet"},{"key":"14835_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14060584","author":"MV Freire","year":"2024","unstructured":"Freire MV, Martin M, Segers K, et al. Digenic inheritance of mutations in homologous recombination genes in cancer patients. J Pers Med. 2024. https:\/\/doi.org\/10.3390\/jpm14060584.","journal-title":"J Pers Med"},{"issue":"2","key":"14835_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/cas.14242","volume":"111","author":"D Shao","year":"2020","unstructured":"Shao D, Cheng S, Guo F, et al. Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals. Cancer Sci. 2020;111(2):647\u201357.","journal-title":"Cancer Sci"},{"issue":"6","key":"14835_CR24","first-page":"1505","volume":"19","author":"J Soukupova","year":"2008","unstructured":"Soukupova J, Dundr P, Kleibl Z, Pohlreich P. Contribution of mutations in ATM to breast cancer development in the Czech population. Oncol Rep. 2008;19(6):1505\u201310.","journal-title":"Oncol Rep"},{"issue":"11","key":"14835_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","volume":"97","author":"D Thompson","year":"2005","unstructured":"Thompson D, Duedal S, Kirner J, et al. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst. 2005;97(11):813\u201322.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"14835_CR26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1053\/j.gastro.2008.12.050","volume":"136","author":"SP Cleary","year":"2009","unstructured":"Cleary SP, Cotterchio M, Jenkins MA, et al. Germline muty human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009;136(4):1251\u201360.","journal-title":"Gastroenterology"},{"issue":"6","key":"14835_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ng.3284","volume":"47","author":"C Cybulski","year":"2015","unstructured":"Cybulski C, Carrot-Zhang J, Klu\u017aniak W, et al. Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet. 2015;47(6):643\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"14835_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.celrep.2016.05.079","volume":"16","author":"H Lu","year":"2016","unstructured":"Lu H, Shamanna RA, Keijzers G, et al. RECQL4 promotes DNA end resection in repair of DNA double-strand breaks. Cell Rep. 2016;16(1):161\u201373.","journal-title":"Cell Rep"},{"key":"14835_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.524128","volume":"10","author":"L Guo","year":"2020","unstructured":"Guo L, Li Y, Zhao C, et al. RECQL4, negatively regulated by miR-10a-5p, facilitates cell proliferation and invasion via MAFB in ovarian cancer. Front Oncol. 2020;10: 524128.","journal-title":"Front Oncol"},{"issue":"1","key":"14835_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2011","unstructured":"Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011;12(1):68\u201378.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"14835_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2(4):482\u201390.","journal-title":"JAMA Oncol"},{"issue":"4","key":"14835_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1158\/1940-6207.CAPR-20-0448","volume":"14","author":"MJ Hall","year":"2021","unstructured":"Hall MJ, Bernhisel R, Hughes E, et al. Germline pathogenic variants in the ataxia telangiectasia mutated (ATM) gene are associated with high and moderate risks for multiple cancers. Cancer Prev Res Phila. 2021;14(4):433\u201340.","journal-title":"Cancer Prev Res Phila"},{"key":"14835_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.16.00066","volume":"1","author":"AW Kurian","year":"2017","unstructured":"Kurian AW, Hughes E, Handorf EA, et al. Breast and ovarian cancer penetrance estimates derived from germline Multiple-Gene sequencing results in women. JCO Precis Oncol. 2017;1:1\u201312.","journal-title":"JCO Precis Oncol"},{"issue":"12","key":"14835_CR34","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1002\/ijc.31013.]","volume":"141","author":"AK Win","year":"2017","unstructured":"Win AK, Reece JC, Dowty JG, et al. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH [published correction appears in. Int J Cancer. 2017;141(12):E7. https:\/\/doi.org\/10.1002\/ijc.31013.]. Int J Cancer.","journal-title":"Int J Cancer"},{"issue":"1","key":"14835_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10549-010-0853-8","volume":"124","author":"M Zuradelli","year":"2010","unstructured":"Zuradelli M, Peissel B, Manoukian S, et al. Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics. Breast Cancer Res Treat. 2010;124(1):251\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"14835_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/genes11121451","author":"MT Vietri","year":"2020","unstructured":"Vietri MT, Caliendo G, D\u2019elia G, et al. Five Italian families with two mutations in BRCA genes. Genes. 2020. https:\/\/doi.org\/10.3390\/genes11121451.","journal-title":"Genes"},{"issue":"3","key":"14835_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10549-024-07454-z","volume":"208","author":"Y Laitman","year":"2024","unstructured":"Laitman Y, Niskakoski A, Bernstein-Molho R, et al. Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes. Breast Cancer Res Treat. 2024;208(3):589\u201395.","journal-title":"Breast Cancer Res Treat"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14835-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14835-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14835-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:58:08Z","timestamp":1757447888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14835-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14835"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14835-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from patients and their families in this study in accordance with the Declaration of Helsinki. This study was approved by Peking University Third Hospital Medical Science Research Ethics Committee (No. 2024 260-01).\u00a0Participants gave informed consent for data to be published anonymously given that the information linked to them would not be released from any researcher.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1391"}}